Fig. 8From: RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccineClinical vaccine effectiveness of the Sinopharm vaccine against infection from the Vokó et al. paper, overplotted with the predicted probability of antibody positivity (> 1 Ci titre) of the present study. Predictions were calculated for males (for visual clarity, as females would have been very similar, evidenced by Fig. 5) and 28 days after vaccinationBack to article page